AbbVie To Switch Track In Alzheimer’s From Tau To Beta-Amyloid

 
• By Joseph Haas
  
Brain decline and dementia or aging as memory loss concept for brain cancer decay or an Alzheimer's disease with old rusting mechanical gears and cog wheels in the shape of a human head with rust.
AbbVie joins the rush to test beta-amyloid hypothesis in Alzheimer's
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business